Clinical Trials Browser

Multiple Myeloma

NCT04031677 2026-03-31

STRASS2

Phase 3 Recruiting

250 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma

NCT06788912 2026-03-31

MK-3475-01E

Phase 2 Recruiting

60 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT07498959 2026-03-27

TESTIGO

Phase NA Recruiting

160 enrolled

Genitourinary

Testicular Neoplasms, Seminoma

NCT04215731 2026-03-03

FOBEAR

Phase 3 Recruiting

582 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05544136 2026-02-27

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Phase 2 Recruiting

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07033819 2026-02-27

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Phase 2 Recruiting

48 enrolled

Gynecologic

Ovarian Neoplasms

NCT06290687 2026-02-18

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Phase 2 Recruiting

40 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Breast

Breast Neoplasms

NCT06107920 2026-02-10

COnCERTO

Phase 3 Recruiting

232 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06386887 2026-02-09

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Phase NA Recruiting

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Intermittent Fasting

NCT06417190 2026-02-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Phase 2 Recruiting

20 enrolled

Tumor-Agnostic

Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

Phase NA Recruiting

180 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

Phase 2 Recruiting

111 enrolled

Breast

Breast Neoplasms

NCT07385001 2026-02-03

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Phase 1/2 Recruiting

45 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04495088 2026-02-02

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Phase 3 Recruiting

550 enrolled

Gastrointestinal

Rectal Neoplasms

NCT07370337 2026-01-27

Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal

Phase 2 Recruiting

50 enrolled

Squamous Cell Carcinoma of External Auditory Canal

NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Phase 2 Recruiting

10 enrolled

Head & Neck

Pathologic Complete Response, Head and Neck Neoplasms

Clinical Trials

CARTITUDE-10

STRASS2

MK-3475-01E

TESTIGO

FOBEAR

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

COnCERTO

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

PRADAIIBE

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer